Green tea and its catechins inhibit breast cancer xenografts

Nutrition and Cancer

Volumn 40, Issue 2, 2001, Pages 149-156

  Sartippour, Maryam R ^a   Heber, David ^a   Ma, Jiyuan ^a   Lu, Qingyi ^a   Go, Vay Liang ^a   Nguyen, Mai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN; GALLOCATECHIN GALLATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG POTENCY; ENDOTHELIUM CELL; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; TUMOR VOLUME; XENOGRAFT;

ANIMALIA;

EID: 0035731418     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC402_11     Document Type: Article

References (55)

1. Introduction: The principles of nutritional oncology
2. Antimutagenic and anticarcinogenic activity of tea polyphenols
3. Tea and cancer prevention: An evaluation of the epidemiologic literature
4. Green tea and cancer in humans: A review of the literature
5. Cancer rates among drinkers of black tea
6. Green tea consumption and the risk of pancreatic and colorectal cancers
7. A case-control study of gastric cancer and diet in Northern Kyushu, Japan
8. A case-control study of cancer of the rectum and colon
9. A comparative case-control study of colorectal cancer and adenoma
10. Dietary habits and gastro-intestinal cancers: A comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan
11. Green tea consumption and risk of stomach cancer: A population-based case-control study in Shanghai, China
12. The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China
13. Physical activity, dietary habits and adenomatous polyps of the sigmoid colon: A study of self-defense officials in Japan
14. Reduced risk of esophageal cancer associated with green tea consumption
15. Tea consumption and lung cancer risk: A case-control study in Okinawa, Japan
16. Lung cancer risk and mutagenicity of tea
17. Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women
18. Mechanistic findings of green tea as cancer preventive for humans
19. Influence of drinking green tea on breast cancer malignancy among Japanese patients
20. Angiogenesis inhibited by drinking tea
21. Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator
22. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity
23. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
24. Novel synthetic analogs of sialyl Lewis X can inhibit angiogenesis in vitro and in vivo
25. The human myoepithelial cell expresses a multifaceted anti-angiogenic phenotype
26. Vascular expression of E-selectin is increased in estrogen receptor-negative breast cancer: A role for tumor cell-secreted IL-1α
27. Thalidomide and chemotherapy combination: Preliminary results of preclinical and clinical studies
28. Different patterns of angiogenesis in sarcomas and carcinomas
29. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
30. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts
31. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate
32. Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma
33. Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression
34. Chemo-protection: A review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents
35. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: Possible role in can cer chemoprevention
36. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR 30 ESR spectrometer system
37. Antioxidants in tea
38. Natural polyphenols (vegetable tannins) as drugs: Possible modes of action
39. Inhibition of tumor promoterinduced activator protein 1 activation and cell transformation by tea polyphenols (-)-epigallocatechin gallate and theoflavins
40. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-KB
41. Anticarcinogenic activity of green tea polyphenols
42. Polyphenols as cancer chemopreventive agents
43. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols
44. Inhibition of carcinogenesis by tea: Bioavailability of tea polyphenols and mechanisms of actions
45. Why drinking tea could prevent cancer
46. Tumor invasion: Molecular shears blunted by green tea
47. Epigallocatechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of cis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172)
48. Tea as a potential chemopreventive agent in PhIP carcinogenesis: Effects of green tea and black tea on PhIP-DNA adduct formation in female F-344 rats
49. Mechanistic findings of green tea as cancer preventive for humans
50. Epigallocatechin suppression of proliferation of vascular smooth cells: Correlation with c-jun and JNK
51. Green tea polyphenols and vitamin E inhibit angiogenesis by suppressing IL-8 (abstr)
52. Lessons from clinical trials of antiangiogenic drugs in the treatment of cancer
53. Phase I and clinical pharmacology study of green tea extract (GTE) in patients with advanced solid tumors (abstr)
54. Phase I trial of green tea extract (GTE) in adult patients with solid tumors (abstr)
55. Green tea experiments in lab, clinic yield mixed results